My Recent Searches
- No Recent Search.
My Tests Viewed
- No Test Viewed.
- Ordering Info
To view specimen requirements and codes please select your laboratory:
Not sure which laboratory serves your office? Call us 1-866-MYQUEST (1-866-697-8378)
HLA-DR4, Flow Cytometry
7 mL whole blood collected in an ACD solution B (yellow-top) tube or 5 mL whole blood collected in a sodium heparin (green-top) tube
3 mL ACD solution (yellow-top) or 1 mL sodium heparin (green-top)
5 mL whole blood collected in an EDTA (lavender-top)
See Preferred Specimen(s)
Received refrigerated • Received frozen
Flow Cytometry (FC)
This test was developed and its performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. Performance characteristics refer to the analytical performance of the test.
A positive result indicates the presence of HLA-DR4 antigen which is associated with an increased risk of an adverse reaction to vaccination with Lyme disease vaccine.
Testing for the presence of HLA-DR4 antigen in a patient is used to determine the potential risk of developing of lyme arthritis from infection with Borrelia burgdorferi or vaccination with lyme vaccine.
Reference ranges are provided as general guidance only. To interpret test results use the reference range in the laboratory report.
(The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.)
* The tests listed by specialist are a select group of tests offered. For a complete list of Quest Diagnostics tests, please refer to our Directory of Services.